STTK
Shattuck Labs, Inc.
NASDAQ · Healthcare · Biotechnology · US
$5.72
−1.46%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 2135.00x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.72x
- Price / sales
- 574.08x
- Price / cash flow
- -13.99x
Enterprise value
- Enterprise value
- $513.5M
- EV / sales
- 513.45x
- EV / EBITDA
- -10.48x
- EV / EBIT
- -9.20x
- Market cap
- $574.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026